Hypoxia: the tumor's gateway to progression along the angiogenic pathway

Author： Brahimi-Horn C. Berra E. Pouyssegur J.

Publisher： Elsevier

ISSN： 0962-8924

Source： Trends in Cell Biology, Vol.11, Iss.11, 2001-11, pp. : 32-36

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypoxia, Clonal Selection, and the Role of HIF-1 in Tumor Progression

By Semenza Gregg L.

Critical Reviews in Biochemistry and Molecular Biology, Vol. 35, Iss. 2, 2000-03 ,pp. : 71-103

Informa Healthcare

Access to resources Recommend Favorite

Assessment and clinical implications of RANK/RANKL/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases

By Milone F.

Biomarkers, Vol. 18, Iss. 2, 2013-03 ,pp. : 121-125

Informa Healthcare

Access to resources Recommend Favorite

Angiogenesis: How a Tumor Adapts to Hypoxia

By Richard D.E. Berra E. Pouysségur J.

Biochemical and Biophysical Research Communications, Vol. 266, Iss. 3, 1999-12 ,pp. : 718-722

Elsevier

Access to resources Recommend Favorite

Membrane trafficking along the phagocytic pathway

By Beron W. Alvarez-Dominguez C. Mayorga L. Stahl P.D.

Trends in Cell Biology, Vol. 5, Iss. 3, 1995-03 ,pp. : 100-104

Elsevier

Access to resources Recommend Favorite

Targeting the hypoxia inducible factor pathway with mitochondrial uncouplers

By Thomas Rusha Kim Myoung

Molecular and Cellular Biochemistry, Vol. 296, Iss. 1-2, 2007-02 ,pp. : 35-44

Springer Publishing Company

Access to resources Recommend Favorite